Dr.
Nicholas J.G. Delva has been appointed Head and District
Chief of the Academic Department of Psychiatry, effective
October 1, 2006.
Dr.
Delva hails from Queen's University,
Kingston
,
Ontario
, where he is Professor of Psychiatry with a
cross-appointment in the Department of Physiology. He has
held academic appointments at Queen's since 1979 when he
began as a lecturer in the Department of Psychiatry.
As
a clinician, he is on the attending staff at Kingston
General and Hotel Dieu hospitals and at Providence
Continuing Care Centre - Mental Health Services, all in
Kingston
. As a researcher, he has focused on biological psychiatry
and his interests include psychopharmacology,
electroconvulsive therapy (ECT), and polydipsia/water
intoxication. He
won the Investigators' Award from the Association for
Convulsive Therapy in 2000, and has over 40 publications
in peer-reviewed journals.
A 1975 graduate of Queen's, Dr. Delva obtained a
Fellowship from the Royal College of Physicians and
Surgeons of Canada (Psychiatry) in 1979. In 1992-93, Dr.
Delva received a traveling fellowship from the Ontario
Mental Health Foundation and the Detweiler Traveling
Fellowship from the Royal College of Physicians and
Surgeons of Canada, allowing him to work with Dr. P. Cowen
at the Psychopharmacology Research Unit,
University
of
Oxford
.
He
is currently a member of the Board of Examiners, Royal
College of Physicians and Surgeons of Canada.
He is the chair of the Canadian Electroconvulsive
Therapy Survey/ Enquête Canadienne sur les Electrochocs (CANECTS/ECANEC)
Committee, which is funded by the Vancouver Coastal Health
Authority. Dr.
Delva's other research activities have recently been
supported via his participation in clinical trials funded
by various pharmaceutical companies, and he has also
received direct support for neuroendocrine studies of the
antidepressant, citalopram.
|
